Literature DB >> 11500083

High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients.

M Cicoira1, A P Bolger, W Doehner, M Rauchhaus, C Davos, R Sharma, F O Al-Nasser, A J Coats, S D Anker.   

Abstract

Immune activation plays an important role in the progression of chronic heart failure (CHF). We sought to investigate whether different degrees of tumor necrosis factor-alpha (TNF-alpha) activation are associated with exercise intolerance, neurohormonal activation and alterations in muscle mass and function in patients with CHF without cardiac cachexia. Patients were divided into quartiles according to their TNF levels (first quartile: 0.98-4.90 pg/ml, second quartile: 5.00-6.60 pg/ml; third quartile 6.80-9.00 pg/ml; fourth quartile 9.80-32.00 pg/ml). Patients underwent cardiopulmonary exercise testing, quadriceps muscle strength test, quadriceps fatigue test, and assessment of thigh muscle and fat cross-sectional area (CSA) by computerized tomography scanning. Patients in the highest TNF quartile had the lowest peak oxygen consumption [13.1 (+/-4.1) ml/kg/min vs 18.1 (+/-5.3), 18.8 (+/-4.8) and 18.7 (+/-5.6) ml/kg/min, P<0.01] the greatest relation of ventilation and dioxide production (VE/VCO(2)) slope (P<0.05) and the most elevated catecholamine levels (P<0.05) compared to patients in the first three quartiles. Patients with the lowest TNF levels had preserved thigh muscle size and quadriceps strength. Strength/muscle CSA was similar in the four groups. Muscle strength during fatigue testing was significantly lower in the fourth quartile (P=0.01) compared with the other three groups. In CHF patients only the highest levels of TNF are associated with poor functional status and neurohormonal activation. This group of patients may represent the appropriate target population for TNF antagonism. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11500083     DOI: 10.1006/cyto.2001.0918

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  19 in total

1.  Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status.

Authors:  M A Spruit; M J Thomeer; R Gosselink; T Troosters; A Kasran; A J T Debrock; M G Demedts; M Decramer
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

2.  Maximal oxygen uptake and exercise tolerance are improved in rats with heart failure subjected to low-level laser therapy associated with resistance training.

Authors:  Vítor Scotta Hentschke; Lucas Capalonga; Douglas Dalcin Rossato; Júlia Luíza Perini; Jadson Pereira Alves; Giuseppe Potrick Stefani; Marlus Karsten; Mauro Pontes; Pedro Dal Lago
Journal:  Lasers Med Sci       Date:  2016-11-17       Impact factor: 3.161

Review 3.  Clinical modifiers for heart failure following myocardial infarction.

Authors:  Nandan S Anavekar; Nagesh S Anavekar
Journal:  Curr Heart Fail Rep       Date:  2005-12

4.  Low-level laser therapy improves the inflammatory profile of rats with heart failure.

Authors:  Vítor S Hentschke; Rodrigo B Jaenisch; Letiane A Schmeing; Paulo R Cavinato; Leder L Xavier; Pedro Dal Lago
Journal:  Lasers Med Sci       Date:  2012-08-31       Impact factor: 3.161

Review 5.  Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure : a clinical review.

Authors:  David R Buvat de Virginy
Journal:  Heart Fail Rev       Date:  2006-12       Impact factor: 4.214

Review 6.  Cachexia in malaria and heart failure: therapeutic considerations in clinical practice.

Authors:  M E Onwuamaegbu; M Henein; A J Coats
Journal:  Postgrad Med J       Date:  2004-11       Impact factor: 2.401

Review 7.  Biomarkers in heart failure: a clinical review.

Authors:  J Paul Rocchiccioli; John J V McMurray; Anna F Dominiczak
Journal:  Heart Fail Rev       Date:  2008-12-03       Impact factor: 4.214

8.  Weight change after myocardial infarction--the Enhancing Recovery in Coronary Heart Disease patients (ENRICHD) experience.

Authors:  Francisco Lopez-Jimenez; Colin O Wu; Xin Tian; Chris O'Connor; Michael W Rich; Matthew M Burg; David Sheps; James Raczynski; Virend K Somers; Allan S Jaffe
Journal:  Am Heart J       Date:  2008-01-15       Impact factor: 4.749

9.  Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I.

Authors:  M A Spruit; R Gosselink; T Troosters; A Kasran; G Gayan-Ramirez; P Bogaerts; R Bouillon; M Decramer
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

10.  TNF signals via neuronal-type nitric oxide synthase and reactive oxygen species to depress specific force of skeletal muscle.

Authors:  Shawn A Stasko; Brian J Hardin; Jeffrey D Smith; Jennifer S Moylan; Michael B Reid
Journal:  J Appl Physiol (1985)       Date:  2013-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.